Søgning
Søgning på udtrykket 'covid' giver 54 resultater
Dokumenter [9] Sider [3] Kalender [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [9]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Ændringer siden version 29: Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo.
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne.
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid.
Kalender [1]
28. maj, Panum Instituttet, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
12.05.2025
…nce synthesis producers. This study aims to assess prospective registration of RCTs included in evidence syntheses as part of a research integrity assessment and examine its impact on the study pool. . Design. Meta-epidemiological study. . Data sources. COVID-19 Cochrane reviews (CRs) and non-Cochrane systematic reviews (SRs) in MEDLINE via PubMed up to 9 June 2022. . Eligibility criteria. RCTs from CRs and SRs evaluating 13 investigational medicinal products for SARS-CoV-2 and COVID-19. .
Journal of Medical Virology
10.05.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
Clinical Microbiology and Infection
10.05.2025
As COVID-19 has transitioned to an endemic disease, there is a need for evidence-based effective strategies to mitigate its public health impacts. This study aims to evaluate the protection offered by vaccination and hybrid immunity, particularly among the elderly, against severe disease by considering their immunological history and individual characteristics.
BMC Infectious Diseases
10.05.2025
. Introduction. The COVID-19 pandemic heightened anxiety among pregnant women, raising concerns about its impact on maternal and fetal health. Although prenatal anxiety is linked to adverse outcomes, the specific relationship between COVID-19-related fear and obstetric complications in quarantined populations remains understudied.
BMJ Open
9.05.2025
. Objectives. Explore what is known about the impact of changes made at a national level to UK postgraduate medical education during COVID-19. . Design. A scoping review, following Arksey and O’Malley’s framework, reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. . Data sources. Ovid MEDLINE, Ovid Embase and ERIC were searched for peer-reviewed literature, and grey literature was searched via DuckDuckGo.
BMC Infectious Diseases
9.05.2025
…r mechanical ventilation progression. Given the link between delayed seroconversion and higher complication risks, we aim to test if evaluating SARS-CoV-2 spike protein antibody status before treatment could enhance IL-6 inhibitor therapy effectiveness in COVID-19 patients. . Methods.
PLoS One Infectious Diseases
8.05.2025
by Iris Delgado, Sushma Dahal, Maria I. Matute, Paola A. Rubilar Ramírez, Svenn-Erik Mamelund, Gerardo Chowell . The COVID-19 pandemic caused an unprecedented economic crisis, intensifying poverty levels in Latin America, particularly in Chile. This study examines the short- and long-term socioeconomic impacts of COVID-19 on income poverty in Chile, focusing on regional disparities, rurality, ethnicity, educational attainment, and immigration.
PLoS One Infectious Diseases
8.05.2025
by Mike Y. Chen, Jeanette Du, Brian K. Do, Mohsin H. Ali . Main objective Compare treatment outcomes of newly diagnosed neovascular age-related macular degeneration (nAMD) during and after the COVID-19 restrictions. Methods This retrospective study at the Retina Group of Washington analyzed nAMD patients treated with anti-VEGF therapy with ≥ 12 months of follow-up. Two groups were identified: 258 subjects diagnosed between March 2020-March 2022 (Group 1) and 376 subjects diagnosed after (Group 2).
PLoS One Infectious Diseases
8.05.2025
by The PLOS One Editors .
Journal of Medical Virology
8.05.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
Journal of Medical Virology
8.05.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
Journal of Medical Virology
8.05.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
International Journal of Infectious Diseases
8.05.2025
Since the emergence of the SARS-CoV-2, the virus responsible of COVID-19, in late 2019, there have been over 776 million reported cases and 7.07 million deaths worldwide as of December 10, 2024 [1]. While the overall incidence of COVID-19 has declined, some regions continue to report cases [1].
PLoS One Infectious Diseases
7.05.2025
…in, Md. Sakhawot Hossain . Background Inadequate dietary diversity is a significant challenge in public health for low-and middle-income countries, including rural communities in Bangladesh. These issues have intensified and become more tragic during the COVID-19 pandemic. This study evaluated the factors associated with household dietary diversity in rural Southwestern Bangladesh during the COVID-19 pandemic.
PLoS One Infectious Diseases
7.05.2025
…t Malhotra, Sanjeev Kumar Gupta, Raman Kumar Marwaha, Ransi Ann Abraham, Monika Arora, Tina Rawal, Maroof Ahmad Khan, Aditi Sinha, Nikhil Tandon . Background Cardio-metabolic risks emerge in early life and progress further in adult life. In recent times, COVID-19 pandemic aggravated risks owing to poor food security and diet quality.
Journal of the American Medical Association
7.05.2025
This study examines post–COVID-19 pandemic cancer screening rates in 2023 relative to previously documented declines through 2021.
International Journal of Infectious Diseases
7.05.2025
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (Mtb), is a strictly airborne pathogen [1] and, until the COVID-19 pandemic, was the leading cause of death from all infectious diseases worldwide. It is increasingly being recognized that other respiratory infections, such as SARS-CoV-2 are also primarily transmitted by aerosols [1]. Airborne transmission is more likely in crowded indoor settings such as healthcare facilities.
BMJ Open
7.05.2025
. Objectives. To compare the incidence and drivers of major adverse kidney events (MAKEs) between COVID-19 and non-COVID-19 acute respiratory distress syndrome (ARDS) patients, with a focus on long-term kidney outcomes. . Design. Retrospective cohort study. . Setting. Single-centre intensive care unit in the Midlands, UK. . Participants. 708 ARDS patients (458 COVID-19, 250 non-COVID-19). . Primary and secondary outcome measures.
PLoS One Infectious Diseases
6.05.2025
…uent vaccination status. Subject and Methods In a sample of UK adults (n=1119) recruited through an online survey platform, vaccination intention was measured on a 0–10 numerical rating scale (0=very unlikely, 10=very likely) at the beginning of the UK COVID-19 vaccination rollout (January 2021), and self-reported vaccination status was gathered after vaccination had been offered to all adults (October 2021).
BMC Infectious Diseases
6.05.2025
. Background. Coronavirus 2019 (COVID-19) disease progression evidence and viral clearance time remain limited in tropical settings. Understanding this is crucial for public health control measures at community-level. We evaluated the viral dynamics of SARS-CoV-2 infection and factors associated with positivity duration in COVID-19 cases in Cameroon. . Material and Methods.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
9.05.2025
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 vaccine recommendations for the upcoming immunization. . Reuters Health Information
Medscape Infectious Diseases
7.05.2025
The administration of influenza and COVID-19 vaccines leads to small changes in the length of the menstrual cycle, particularly when administering during the follicular phase. . Medscape News UK
Medscape Infectious Diseases
1.05.2025
China restated its case that COVID-19 may have originated in the United States in a white paper on its pandemic response released on Wednesday after President Donald Trump's. . Reuters Health Information
Medscape Infectious Diseases
30.04.2025
Pope Francis’ health crisis highlights the delicate balance between transparency and privacy, particularly if COVID-19 had been involved and the global reaction it could have provoked. . Medscape UK
Medscape Infectious Diseases
29.04.2025
The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, easy-to-administer solution. . Medscape News UK
Statens Serum Institut
25.04.2025
Nyt dansk studie viser, at de opdaterede covid-19-vacciner fortsat beskytter effektivt mod alvorlig sygdom og død – også over for nye virusvarianter.
Morbidity and Mortality Weekly Report (MMWR)
25.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Medscape Infectious Diseases
25.04.2025
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert. . Reuters Health Information
Medscape Infectious Diseases
21.04.2025
Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps forward this year. . Medscape Medical News
Medscape Infectious Diseases
14.04.2025
In patients hospitalised for COVID-19, fatigue, memory and cognitive problems worsened between years 2 and 3 post-discharge; nearly one third of patients developed PEM at 3 years, a study finds. . Medscape News UK
ProMED
13.04.2025
…ttp://www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Thu 10 Apr 2025 . Source: CIDRAP (Center for Infectious Disease Research & Policy). [edited] . www.cidrap.umn.edu/covid-19/using-study-design-past-researchers-again-show-covid-19-airborne . . . In 1959, researchers built a facility near Pretoria, South Africa, to. study the airborne route of tuberculosis transmission, replicating an.
Medscape Infectious Diseases
8.04.2025
NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains in doubt. . Medscape Medical News
Medscape Infectious Diseases
8.04.2025
New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing immune dysfunction and potential treatment targets. . Medscape Medical News
Medscape Infectious Diseases
4.04.2025
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, the company told Reuters on. . Reuters Health Information
ProMED
2.04.2025
…******************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . In this update: . [1] Russia: Publication of daily COVID-19 reports halted . [2] Macau: COVID-19 positive rate at 40%; 2 health bureaus urge. vaccination . [3] Hong Kong: Local influenza activity continues to decline, COVID-19. activity begins to rise slightly .
Morbidity and Mortality Weekly Report (MMWR)
1.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ECDC COVID-19 updates
26.03.2025
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
26.03.2025
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
ECDC COVID-19 updates
22.03.2025
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
Medscape Infectious Diseases
19.03.2025
After COVID-19, RSV cases appear earlier and result in more severe illness in infants, with increased oxygen and ventilation needs, a new study reports. . Medscape News UK